Sept. 30, 2024 – A recent study accepted by the American Society of Radiation Oncology (ASTRO) for their annual meeting in Washington D.C. demonstrates a significant reduction in radiation Planning Target Volume involving patients who received Breast Conserving Surgery (lumpectomy), a VeraForm marker for cavity delineation and Accelerated Partial Breast Irradiation (APBI) along with Deep Inspiration Breath Hold (DIBH) for motion management. 

Oct. 2, 2024 – On Oct. 2, Proscia launched Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics. Integrated into Proscia’s Concentriq platform, Concentriq Embeddings delivers a collection of pathology foundation models to AI developers and research scientists, allowing them to leverage their organization's large proprietary datasets and execute models in routine workflows.

Sept. 3, 2024 — Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study’s results were published in Radiology, a journal of the Radiological Society of North America (RSNA).

According to a study published in Radiology, a journal of the Radiological Society of North America, the newer, 3D form of breast screening, known as digital breast tomosynthesis (DBT), is more effective at detecting breast cancer than traditional 2D digital mammography (DM).

Sept. 19, 2024 – Medical imaging AI company Avicenna.AI recently announced it had received 510(k) clearance from the U.S. Food and Drug Administration for its CINA-CSpine tool.

CINA-CSpine is an AI tool designed to support the detection and triage of cervical spine fractures from CT images.